Concepedia

Samar Alanazi

SA

5

Publications

296

Citations

5

H-Index

2018

Active since

Affiliations

University of Cincinnati Medical Center(Current)

University of Cincinnati

Samar Alanazi is an author at University of Cincinnati Medical Center specializing in radiation oncology, oncology, and tumor biology.

ORCID

Top concepts

Publications per year

2018–2021

5

Publications

5

HER3 signaling and targeted therapy in cancer

Rosalin Mishra, Hima Patel, Samar Alanazi et al. · Oncology Reviews · 2018 · 181 citations · Full text

Activating HER3 mutations in breast cancer

Rosalin Mishra, Samar Alanazi, Long Yuan et al. · Oncotarget · 2018 · 36 citations · Full text

IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma

Hima Patel, Rosalin Mishra, Nour Yacoub et al. · Cancers · 2021 · 31 citations · Full text

, , +14

BRAF Mutant Melanoma Adjusts to BRAF/MEK Inhibitors via Dependence on Increased Antioxidant SOD2 and Increased Reactive Oxygen Species Levels

Long Yuan, Rosalin Mishra, Hima Patel et al. · Cancers · 2020 · 29 citations · Full text

, , +16

Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth

Rosalin Mishra, Long Yuan, Hima Patel et al. · International Journal of Molecular Sciences · 2021 · 19 citations · Full text

Rows per page

1–5 of 5